Skip to content

Opus Genetics IRD Interest Paid

Interest Paid at other companies

AbbVie logo
AbbVieABBV
$750.5M+6.8%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$2.71M-5.3%
Opko Health logo
Opko HealthOPK
$9.6M-30.2%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$10.4M-20.9%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$1.22M+385%
uniQure logo
uniQureQURE
$6.72M+3.5%

Other financials

Income statement

See full
Revenue$2.2M-50.6%
Operating income-$14.4M-44.7%
Net income-$65.5M-700%
EPS (diluted)-$0.75-213%

Balance sheet

See full
Cash & equivalents$60.0M+43.5%
Total debt$1.2M
Total equity-$45.8M-1,004%
Total assets$66.8M+38.7%

Cash flow

See full
Operating cash flow-$12.7M-41.5%

Valuation

See full
Market cap$307.14M+442%
Enterprise value$248.38M
P/S25.6×+21.5×

Profitability

See full
Operating margin-359.1%-68.9pp
Net margin-892.4%-12,322pp

Returns & leverage

See full
Return on equity-449.4%-2,573pp
Debt / equity0.1×
Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opus Genetics's interest paid?
Opus Genetics (IRD) reported interest paid of $0 in Q1 2026.
What is the long-term trend for Opus Genetics's interest paid?
Over 3 years (2021 to 2025), Opus Genetics's interest paid has grown at a -100.0% compound annual growth rate (CAGR), from $2K to $0.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.